Skip to main content
Top
Published in: Journal of Endocrinological Investigation 1/2021

01-01-2021 | Stroke | Original Article

BMI modifies the association between serum HDL cholesterol and stroke in a hypertensive population without atrial fibrillation

Authors: Y. Yu, L. Hu, X. Huang, W. Zhou, H. Bao, X. Cheng

Published in: Journal of Endocrinological Investigation | Issue 1/2021

Login to get access

Abstract

Purpose

Both high-density lipoprotein cholesterol (HDL-C) and body mass index (BMI) have an impact on the prevalence of stroke. However, it is unclear whether BMI can modify the relationship between HDL-C and stroke. Therefore, we aimed to assess the effect of the BMI on the association between HDL-C and stroke in a hypertensive population without atrial fibrillation (AF).

Methods

We analyzed data of 10,925 hypertensive patients without AF from the Chinese Hypertension Registry Study. BMI was categorized as < 24 and ≥ 24 kg/m2. Multivariate logistic regression and smooth curve fitting (penalized spline method) were used to analyze the association between HDL-C and stroke in different BMI groups. Subgroup analysis and interaction tests were used to explore the effect of other variables on this relationship.

Results

The results showed a negative association between HDL-C and stroke in the BMI < 24 kg/m2 group, but HDL-C was not associated with stroke in the BMI ≥ 24 kg/m2 group. In the BMI < 24 kg/m2 group, each 1 mmol/L increase in HDL-C was associated with a 50% decreased risk of stroke [odds ratio (OR) 0.50, 95% confidence interval (CI) 0.38–0.66]. No significant relationship between HDL-C and stroke was observed in the BMI ≥ 24 kg/m2 group (OR 0.73, 95% CI 0.49–1.10). There was a significant interaction between BMI and HDL-C in regard to the prevalence of stroke in the hypertensive population without AF (PInteraction = 0.027).

Conclusions

We found an inverse association between HDL-C and stroke only in the BMI < 24 kg/m2 group. The finding suggested that BMI could modify the association between HDL-C and stroke in hypertensive populations without AF.
Appendix
Available only for authorised users
Literature
1.
go back to reference Wu S, Wu B, Liu M, Chen Z, Wang W, Anderson CS et al (2019) Stroke in China: advances and challenges in epidemiology, prevention, and management. Lancet Neurol 18:394–405PubMedCrossRef Wu S, Wu B, Liu M, Chen Z, Wang W, Anderson CS et al (2019) Stroke in China: advances and challenges in epidemiology, prevention, and management. Lancet Neurol 18:394–405PubMedCrossRef
2.
go back to reference O'Donnell MJ, Xavier D, Liu L, Zhang H, Chin SL, Rao-Melacini P et al (2010) Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet 376:112–123PubMedCrossRef O'Donnell MJ, Xavier D, Liu L, Zhang H, Chin SL, Rao-Melacini P et al (2010) Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet 376:112–123PubMedCrossRef
3.
go back to reference de Beer FC, Connell PM, Yu J, de Beer MC, Webb NR, van der Westhuyzen DR (2000) HDL modification by secretory phospholipase A(2) promotes scavenger receptor class B type I interaction and accelerates HDL catabolism. J Lipid Res 41:1849–1857PubMedCrossRef de Beer FC, Connell PM, Yu J, de Beer MC, Webb NR, van der Westhuyzen DR (2000) HDL modification by secretory phospholipase A(2) promotes scavenger receptor class B type I interaction and accelerates HDL catabolism. J Lipid Res 41:1849–1857PubMedCrossRef
4.
go back to reference Gordon DJ, Probstfield JL, Garrison RJ, Neaton JD, Castelli WP, Knoke JD et al (1989) High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 79:8–15PubMedCrossRef Gordon DJ, Probstfield JL, Garrison RJ, Neaton JD, Castelli WP, Knoke JD et al (1989) High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 79:8–15PubMedCrossRef
5.
go back to reference Kitamura A, Iso H, Naito Y, Iida M, Konishi M, Folsom AR et al (1994) High-density lipoprotein cholesterol and premature coronary heart disease in urban Japanese men. Circulation 89:2533–2539PubMedCrossRef Kitamura A, Iso H, Naito Y, Iida M, Konishi M, Folsom AR et al (1994) High-density lipoprotein cholesterol and premature coronary heart disease in urban Japanese men. Circulation 89:2533–2539PubMedCrossRef
6.
go back to reference Acharjee S, Boden WE, Hartigan PM, Teo KK, Maron DJ, Sedlis SP et al (2013) Low levels of high-density lipoprotein cholesterol and increased risk of cardiovascular events in stable ischemic heart disease patients: a post-hoc analysis from the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation). J Am Coll Cardiol 62:1826–1833PubMedPubMedCentralCrossRef Acharjee S, Boden WE, Hartigan PM, Teo KK, Maron DJ, Sedlis SP et al (2013) Low levels of high-density lipoprotein cholesterol and increased risk of cardiovascular events in stable ischemic heart disease patients: a post-hoc analysis from the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation). J Am Coll Cardiol 62:1826–1833PubMedPubMedCentralCrossRef
7.
go back to reference Curb JD, Abbott RD, Rodriguez BL, Masaki KH, Chen R, Popper JS et al (2004) High density lipoprotein cholesterol and the risk of stroke in elderly men: the Honolulu heart program. Am J Epidemiol 160:150–157PubMedCrossRef Curb JD, Abbott RD, Rodriguez BL, Masaki KH, Chen R, Popper JS et al (2004) High density lipoprotein cholesterol and the risk of stroke in elderly men: the Honolulu heart program. Am J Epidemiol 160:150–157PubMedCrossRef
8.
go back to reference Soyama Y, Miura K, Morikawa Y, Nishijo M, Nakanishi Y, Naruse Y et al (2003) High-density lipoprotein cholesterol and risk of stroke in Japanese men and women: the Oyabe Study. Stroke 34:863–868PubMedCrossRef Soyama Y, Miura K, Morikawa Y, Nishijo M, Nakanishi Y, Naruse Y et al (2003) High-density lipoprotein cholesterol and risk of stroke in Japanese men and women: the Oyabe Study. Stroke 34:863–868PubMedCrossRef
9.
go back to reference Zhang Y, Tuomilehto J, Jousilahti P, Wang Y, Antikainen R, Hu G (2012) Total and high-density lipoprotein cholesterol and stroke risk. Stroke 43:1768–1774PubMedCrossRef Zhang Y, Tuomilehto J, Jousilahti P, Wang Y, Antikainen R, Hu G (2012) Total and high-density lipoprotein cholesterol and stroke risk. Stroke 43:1768–1774PubMedCrossRef
10.
go back to reference Bowman TS, Sesso HD, Ma J, Kurth T, Kase CS, Stampfer MJ et al (2003) Cholesterol and the risk of ischemic stroke. Stroke 34:2930–2934PubMedCrossRef Bowman TS, Sesso HD, Ma J, Kurth T, Kase CS, Stampfer MJ et al (2003) Cholesterol and the risk of ischemic stroke. Stroke 34:2930–2934PubMedCrossRef
11.
go back to reference Koren-Morag N, Tanne D, Graff E, Goldbourt U (2002) Low- and high-density lipoprotein cholesterol and ischemic cerebrovascular disease: the bezafibrate infarction prevention registry. Arch Intern Med 162:993–999PubMedCrossRef Koren-Morag N, Tanne D, Graff E, Goldbourt U (2002) Low- and high-density lipoprotein cholesterol and ischemic cerebrovascular disease: the bezafibrate infarction prevention registry. Arch Intern Med 162:993–999PubMedCrossRef
12.
go back to reference Wang X, Dong Y, Qi X, Huang C, Hou L (2013) Cholesterol levels and risk of hemorrhagic stroke: a systematic review and meta-analysis. Stroke 44:1833–1839PubMedCrossRef Wang X, Dong Y, Qi X, Huang C, Hou L (2013) Cholesterol levels and risk of hemorrhagic stroke: a systematic review and meta-analysis. Stroke 44:1833–1839PubMedCrossRef
13.
14.
go back to reference Zhou B (2002) Predictive values of body mass index and waist circumference to risk factors of related diseases in Chinese adult population. Zhonghua Liu Xing Bing Xue Za Zhi 23:5–10PubMed Zhou B (2002) Predictive values of body mass index and waist circumference to risk factors of related diseases in Chinese adult population. Zhonghua Liu Xing Bing Xue Za Zhi 23:5–10PubMed
15.
go back to reference Chen C, Lu FC (2004) The guidelines for prevention and control of overweight and obesity in Chinese adults. Biomed Environ Sci 17(Suppl):1–36PubMed Chen C, Lu FC (2004) The guidelines for prevention and control of overweight and obesity in Chinese adults. Biomed Environ Sci 17(Suppl):1–36PubMed
16.
go back to reference (2019) 2018 Chinese Guidelines for Prevention and Treatment of Hypertension—a report of the Revision Committee of Chinese Guidelines for Prevention and Treatment of Hypertension. J Geriatr Cardiol 16:182–241 (2019) 2018 Chinese Guidelines for Prevention and Treatment of Hypertension—a report of the Revision Committee of Chinese Guidelines for Prevention and Treatment of Hypertension. J Geriatr Cardiol 16:182–241
17.
go back to reference Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B et al (2016) 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 37:2893–2962CrossRefPubMed Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B et al (2016) 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 37:2893–2962CrossRefPubMed
18.
go back to reference Hu L, Huang X, Zhou W, You C, Li J, Li P et al (2020) Effect of hypertension status on the association between sleep duration and stroke among middle-aged and elderly population. J Clin Hypertens (Greenwich) 22:65–73CrossRef Hu L, Huang X, Zhou W, You C, Li J, Li P et al (2020) Effect of hypertension status on the association between sleep duration and stroke among middle-aged and elderly population. J Clin Hypertens (Greenwich) 22:65–73CrossRef
19.
go back to reference Catapano AL, Graham I, De Backer G, Wiklund O, Chapman MJ, Drexel H et al (2016) 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias. Eur Heart J 37:2999–3058PubMedCrossRef Catapano AL, Graham I, De Backer G, Wiklund O, Chapman MJ, Drexel H et al (2016) 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias. Eur Heart J 37:2999–3058PubMedCrossRef
20.
go back to reference Sturgeon JD, Folsom AR, Longstreth WJ, Shahar E, Rosamond WD, Cushman M (2007) Risk factors for intracerebral hemorrhage in a pooled prospective study. Stroke 38:2718–2725PubMedCrossRef Sturgeon JD, Folsom AR, Longstreth WJ, Shahar E, Rosamond WD, Cushman M (2007) Risk factors for intracerebral hemorrhage in a pooled prospective study. Stroke 38:2718–2725PubMedCrossRef
21.
go back to reference Noda H, Iso H, Irie F, Sairenchi T, Ohtaka E, Doi M et al (2009) Low-density lipoprotein cholesterol concentrations and death due to intraparenchymal hemorrhage: the Ibaraki Prefectural Health Study. Circulation 119:2136–2145PubMedCrossRef Noda H, Iso H, Irie F, Sairenchi T, Ohtaka E, Doi M et al (2009) Low-density lipoprotein cholesterol concentrations and death due to intraparenchymal hemorrhage: the Ibaraki Prefectural Health Study. Circulation 119:2136–2145PubMedCrossRef
22.
go back to reference Wieberdink RG, Poels MM, Vernooij MW, Koudstaal PJ, Hofman A, van der Lugt A et al (2011) Serum lipid levels and the risk of intracerebral hemorrhage: the Rotterdam Study. Arterioscler Thromb Vasc Biol 31:2982–2989PubMedCrossRef Wieberdink RG, Poels MM, Vernooij MW, Koudstaal PJ, Hofman A, van der Lugt A et al (2011) Serum lipid levels and the risk of intracerebral hemorrhage: the Rotterdam Study. Arterioscler Thromb Vasc Biol 31:2982–2989PubMedCrossRef
23.
go back to reference Leppala JM, Virtamo J, Fogelholm R, Albanes D, Heinonen OP (1999) Different risk factors for different stroke subtypes: association of blood pressure, cholesterol, and antioxidants. Stroke 30:2535–2540PubMedCrossRef Leppala JM, Virtamo J, Fogelholm R, Albanes D, Heinonen OP (1999) Different risk factors for different stroke subtypes: association of blood pressure, cholesterol, and antioxidants. Stroke 30:2535–2540PubMedCrossRef
24.
go back to reference Tirschwell DL, Smith NL, Heckbert SR, Lemaitre RN, Longstreth WJ, Psaty BM (2004) Association of cholesterol with stroke risk varies in stroke subtypes and patient subgroups. Neurology 63:1868–1875PubMedCrossRef Tirschwell DL, Smith NL, Heckbert SR, Lemaitre RN, Longstreth WJ, Psaty BM (2004) Association of cholesterol with stroke risk varies in stroke subtypes and patient subgroups. Neurology 63:1868–1875PubMedCrossRef
25.
go back to reference Ishitsuka K, Kamouchi M, Hata J, Fukuda K, Matsuo R, Kuroda J et al (2014) High blood pressure after acute ischemic stroke is associated with poor clinical outcomes: Fukuoka Stroke Registry. Hypertension 63:54–60PubMedCrossRef Ishitsuka K, Kamouchi M, Hata J, Fukuda K, Matsuo R, Kuroda J et al (2014) High blood pressure after acute ischemic stroke is associated with poor clinical outcomes: Fukuoka Stroke Registry. Hypertension 63:54–60PubMedCrossRef
26.
go back to reference Rosenson RS, Lowe GD (1998) Effects of lipids and lipoproteins on thrombosis and rheology. Atherosclerosis 140:271–280PubMedCrossRef Rosenson RS, Lowe GD (1998) Effects of lipids and lipoproteins on thrombosis and rheology. Atherosclerosis 140:271–280PubMedCrossRef
27.
28.
go back to reference Nicholas JS, Swearingen CJ, Thomas JC, Rumboldt Z, Tumminello P, Patel SJ (2008) The effect of statin pretreatment on infarct volume in ischemic stroke. Neuroepidemiology 31:48–56PubMedCrossRef Nicholas JS, Swearingen CJ, Thomas JC, Rumboldt Z, Tumminello P, Patel SJ (2008) The effect of statin pretreatment on infarct volume in ischemic stroke. Neuroepidemiology 31:48–56PubMedCrossRef
29.
go back to reference Bots ML, Elwood PC, Nikitin Y, Salonen JT, Freire DCA, Inzitari D et al (2002) Total and HDL cholesterol and risk of stroke. EUROSTROKE: a collaborative study among research centres in Europe. J Epidemiol Community Health 56(Suppl 1):i19–24PubMedPubMedCentralCrossRef Bots ML, Elwood PC, Nikitin Y, Salonen JT, Freire DCA, Inzitari D et al (2002) Total and HDL cholesterol and risk of stroke. EUROSTROKE: a collaborative study among research centres in Europe. J Epidemiol Community Health 56(Suppl 1):i19–24PubMedPubMedCentralCrossRef
30.
go back to reference Wang P, Xu TY, Guan YF, Su DF, Fan GR, Miao CY (2009) Perivascular adipose tissue-derived visfatin is a vascular smooth muscle cell growth factor: role of nicotinamide mononucleotide. Cardiovasc Res 81:370–380PubMedCrossRef Wang P, Xu TY, Guan YF, Su DF, Fan GR, Miao CY (2009) Perivascular adipose tissue-derived visfatin is a vascular smooth muscle cell growth factor: role of nicotinamide mononucleotide. Cardiovasc Res 81:370–380PubMedCrossRef
31.
go back to reference Marra F, Navari N, Vivoli E, Galastri S, Provenzano A (2011) Modulation of liver fibrosis by adipokines. Dig Dis 29:371–376PubMedCrossRef Marra F, Navari N, Vivoli E, Galastri S, Provenzano A (2011) Modulation of liver fibrosis by adipokines. Dig Dis 29:371–376PubMedCrossRef
32.
go back to reference Badellino KO, Wolfe ML, Reilly MP, Rader DJ (2006) Endothelial lipase concentrations are increased in metabolic syndrome and associated with coronary atherosclerosis. Plos Med 3:e22PubMedCrossRef Badellino KO, Wolfe ML, Reilly MP, Rader DJ (2006) Endothelial lipase concentrations are increased in metabolic syndrome and associated with coronary atherosclerosis. Plos Med 3:e22PubMedCrossRef
33.
go back to reference Hahn BH, Lourencco EV, McMahon M, Skaggs B, Le E, Anderson M et al (2010) Pro-inflammatory high-density lipoproteins and atherosclerosis are induced in lupus-prone mice by a high-fat diet and leptin. Lupus 19:913–917PubMedPubMedCentralCrossRef Hahn BH, Lourencco EV, McMahon M, Skaggs B, Le E, Anderson M et al (2010) Pro-inflammatory high-density lipoproteins and atherosclerosis are induced in lupus-prone mice by a high-fat diet and leptin. Lupus 19:913–917PubMedPubMedCentralCrossRef
34.
go back to reference Sorrentino SA, Besler C, Rohrer L, Meyer M, Heinrich K, Bahlmann FH et al (2010) Endothelial-vasoprotective effects of high-density lipoprotein are impaired in patients with type 2 diabetes mellitus but are improved after extended-release niacin therapy. Circulation 121:110–122PubMedCrossRef Sorrentino SA, Besler C, Rohrer L, Meyer M, Heinrich K, Bahlmann FH et al (2010) Endothelial-vasoprotective effects of high-density lipoprotein are impaired in patients with type 2 diabetes mellitus but are improved after extended-release niacin therapy. Circulation 121:110–122PubMedCrossRef
35.
go back to reference Sasahara T, Yamashita T, Sviridov D, Fidge N, Nestel P (1997) Altered properties of high density lipoprotein subfractions in obese subjects. J Lipid Res 38:600–611PubMedCrossRef Sasahara T, Yamashita T, Sviridov D, Fidge N, Nestel P (1997) Altered properties of high density lipoprotein subfractions in obese subjects. J Lipid Res 38:600–611PubMedCrossRef
36.
go back to reference Tan G, Lei C, Hao Z, Chen Y, Yuan R, Liu M (2016) Liver function may play an uneven role in haemorrhagic transformation for stroke subtypes after acute ischaemic stroke. Eur J Neurol 23:597–604PubMedCrossRef Tan G, Lei C, Hao Z, Chen Y, Yuan R, Liu M (2016) Liver function may play an uneven role in haemorrhagic transformation for stroke subtypes after acute ischaemic stroke. Eur J Neurol 23:597–604PubMedCrossRef
37.
go back to reference Tan G, Hao Z, Lei C, Chen Y, Yuan R, Xu M et al (2016) Subclinical change of liver function could also provide a clue on prognosis for patients with spontaneous intracerebral hemorrhage. Neurol Sci 37:1693–1700PubMedCrossRef Tan G, Hao Z, Lei C, Chen Y, Yuan R, Xu M et al (2016) Subclinical change of liver function could also provide a clue on prognosis for patients with spontaneous intracerebral hemorrhage. Neurol Sci 37:1693–1700PubMedCrossRef
38.
go back to reference Vemmos K, Ntaios G, Spengos K, Savvari P, Vemmou A, Pappa T et al (2011) Association between obesity and mortality after acute first-ever stroke: the obesity-stroke paradox. Stroke 42:30–36PubMedCrossRef Vemmos K, Ntaios G, Spengos K, Savvari P, Vemmou A, Pappa T et al (2011) Association between obesity and mortality after acute first-ever stroke: the obesity-stroke paradox. Stroke 42:30–36PubMedCrossRef
39.
go back to reference Xu J, Wang A, Meng X, Jing J, Wang Y, Wang Y (2019) Obesity-stroke paradox exists in insulin-resistant patients but not insulin sensitive patients. Stroke 50:A118023817 Xu J, Wang A, Meng X, Jing J, Wang Y, Wang Y (2019) Obesity-stroke paradox exists in insulin-resistant patients but not insulin sensitive patients. Stroke 50:A118023817
40.
go back to reference Gorelick PB, Richardson D, Kelly M, Ruland S, Hung E, Harris Y et al (2003) Aspirin and ticlopidine for prevention of recurrent stroke in black patients: a randomized trial. JAMA 289:2947–2957PubMedCrossRef Gorelick PB, Richardson D, Kelly M, Ruland S, Hung E, Harris Y et al (2003) Aspirin and ticlopidine for prevention of recurrent stroke in black patients: a randomized trial. JAMA 289:2947–2957PubMedCrossRef
41.
go back to reference Huo Y, Li J, Qin X, Huang Y, Wang X, Gottesman RF et al (2015) Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China: the CSPPT randomized clinical trial. JAMA 313:1325–1335PubMedCrossRef Huo Y, Li J, Qin X, Huang Y, Wang X, Gottesman RF et al (2015) Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China: the CSPPT randomized clinical trial. JAMA 313:1325–1335PubMedCrossRef
42.
go back to reference Staessen JA, Kuznetsova T, Stolarz K (2003) Hypertension prevalence and stroke mortality across populations. JAMA 289:2420–2422PubMedCrossRef Staessen JA, Kuznetsova T, Stolarz K (2003) Hypertension prevalence and stroke mortality across populations. JAMA 289:2420–2422PubMedCrossRef
43.
go back to reference Wang W, Jiang B, Sun H, Ru X, Sun D, Wang L et al (2017) Prevalence, incidence, and mortality of stroke in China: results from a nationwide population-based survey of 480 687 adults. Circulation 135:759–771PubMedCrossRef Wang W, Jiang B, Sun H, Ru X, Sun D, Wang L et al (2017) Prevalence, incidence, and mortality of stroke in China: results from a nationwide population-based survey of 480 687 adults. Circulation 135:759–771PubMedCrossRef
Metadata
Title
BMI modifies the association between serum HDL cholesterol and stroke in a hypertensive population without atrial fibrillation
Authors
Y. Yu
L. Hu
X. Huang
W. Zhou
H. Bao
X. Cheng
Publication date
01-01-2021
Publisher
Springer International Publishing
Published in
Journal of Endocrinological Investigation / Issue 1/2021
Electronic ISSN: 1720-8386
DOI
https://doi.org/10.1007/s40618-020-01288-4

Other articles of this Issue 1/2021

Journal of Endocrinological Investigation 1/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.